{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:34Z","timestamp":1793608054503,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021041","name":"American College of Allergy, Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.anai.2026.02.018","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T15:02:00Z","timestamp":1772377320000},"page":"720-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and management of pediatric and adolescent hereditary angioedema"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-3733","authenticated-orcid":false,"given":"Andrew","family":"MacGinnitie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0001","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1160\/TH12-08-0549","article-title":"Hereditary angioedema: a bradykinin-mediated swelling disorder","volume":"109","author":"Bjorkqvist","year":"2013","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.anai.2026.02.018_bib0002","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100627","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update","volume":"15","author":"Maurer","year":"2022","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2500\/aap.2015.36.3806","article-title":"Hereditary angioedema with a focus on the child","volume":"36","author":"Bennett","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.anai.2026.02.018_bib0006","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0009922815616886","article-title":"Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity","volume":"55","author":"Christiansen","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"issue":"7","key":"10.1016\/j.anai.2026.02.018_bib0007","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2020.02.043","article-title":"Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema-A long-term survey","volume":"8","author":"Farkas","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0008","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.mayocpiqo.2020.06.004","article-title":"Hereditary angioedema attack in utero and treatment of the mother and fetus","volume":"4","author":"Grivcheva-Panovska","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0009","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2411","article-title":"Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns","volume":"137","author":"Martinez-Saguer","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0010","doi-asserted-by":"crossref","first-page":"484.e1","DOI":"10.1016\/j.ajog.2008.04.034","article-title":"Disease expression in women with hereditary angioedema","volume":"199","author":"Bouillet","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.anai.2026.02.018_bib0011","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MCG.0000000000001744","article-title":"Consider hereditary angioedema in the differential diagnosis for unexplained recurring abdominal pain","volume":"56","author":"Staller","year":"2022","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1710-1492-6-18","article-title":"Pediatric hereditary angioedema due to C1-inhibitor deficiency","volume":"6","author":"Farkas","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0014","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaip.2014.11.012","article-title":"Clinical features of pediatric hereditary angioedema","volume":"3","author":"Nanda","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0016","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","article-title":"Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States","volume":"124","author":"Banerji","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0017","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10875-015-0222-9","article-title":"Complement Study versus CINH gene testing for the diagnosis of Type I hereditary angioedema in children","volume":"36","author":"Pedrosa","year":"2016","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.imbio.2011.07.027","article-title":"Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth","volume":"217","author":"McGreal","year":"2012","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.anai.2026.02.018_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/sji.12154","article-title":"Complement profile in neonates of different gestational ages","volume":"79","author":"Grumach","year":"2014","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40272-017-0273-x","article-title":"Pharmacological management of hereditary angioedema with C1-inhibitor deficiency in pediatric patients","volume":"20","author":"Farkas","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13223-025-00950-x","article-title":"Early diagnosis of hereditary angioedema in children: genetic testing should be prioritized","volume":"21","author":"Bocquet","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2009.12.004","article-title":"Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?","volume":"104","author":"Lunn","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2026.02.018_bib0024","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1203\/00006450-197909000-00019","article-title":"Serum complement levels in infancy: age related changes","volume":"13","author":"Davis","year":"1979","journal-title":"Pediatr Res"},{"issue":"13","key":"10.1016\/j.anai.2026.02.018_bib0025","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1016\/j.molimm.2008.05.007","article-title":"Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates","volume":"45","author":"Pappalardo","year":"2008","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/aap.2024.45.240010","article-title":"Hereditary angioedema with normal C1 esterase inhibitor: current paradigms and clinical dilemmas","volume":"45","author":"Radojicic","year":"2024","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0027","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jaip.2025.02.036","article-title":"Hereditary angioedema with normal C1 inhibitor: a quarter century of forward progress and persisting obstacles","volume":"13","author":"Christiansen","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2026.02.018_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12317","article-title":"Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema","volume":"13","author":"Iurascu","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0029","article-title":"Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency","volume":"4","author":"Bernstein","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"4","key":"10.1016\/j.anai.2026.02.018_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/pai.12712","article-title":"Health-related quality of life among children with hereditary angioedema","volume":"28","author":"Engel-Yeger","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0031","first-page":"237","article-title":"Clinical characteristics and quality of life in a cohort of polish pediatric patients with hereditary angioedema","volume":"11","author":"Piotrowicz-Wojcik","year":"2024","journal-title":"Children (Basel)"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0032","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2500\/aap.2021.42.210025","article-title":"Patient perspectives on the treatment burden of injectable medication for hereditary angioedema","volume":"42","author":"Radojicic","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0033","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.2500\/aap.2025.46.250017","article-title":"Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment","volume":"46","author":"Akten","year":"2025","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0034","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.anai.2026.02.018_bib0035","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.anai.2026.02.018_bib0036","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-9-44","article-title":"The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency","volume":"9","author":"Zotter","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.11.025","article-title":"International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency","volume":"129","author":"Caballero","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0038","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/all.14144","article-title":"Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema","volume":"75","author":"Weller","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0039","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2500\/ar.2015.6.0112","article-title":"Perioperative management for patients with hereditary angioedema","volume":"6","author":"Williams","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"issue":"8","key":"10.1016\/j.anai.2026.02.018_bib0040","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jaip.2023.04.017","article-title":"Hereditary angioedema: a review of the current and evolving treatment landscape","volume":"11","author":"Betschel","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0041","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.anai.2024.12.012","article-title":"On-demand treatment of hereditary angioedema attacks: patient-reported utilization, barriers, and outcomes","volume":"134","author":"Christiansen","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0042","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/11201100-000000000-00000","article-title":"Human C1-esterase inhibitor concentrate (Berinert)","volume":"23","author":"Keating","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.anai.2026.02.018_bib0043","unstructured":"Berinert [package insert]. Kankakee, IL: CSL Behring LLC; 2021."},{"issue":"12","key":"10.1016\/j.anai.2026.02.018_bib0044","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1398-9995.2011.02702.x","article-title":"C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks\u2013final results of the I.M.P.A.C.T.2 study","volume":"66","author":"Craig","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2026.02.018_bib0045","unstructured":"Ruconest [package insert]. Leiden, Netherlands: Pharming. 2020."},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0046","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2013.12.004","article-title":"Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial","volume":"112","author":"Riedl","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.02.018_bib0047","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2010.07.021","article-title":"Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema","volume":"126","author":"Zuraw","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.02.018_bib0048","unstructured":"Kalbitor [package insert]. Cambridge, MA: Takeda Pharmaceuticals; 2025."},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0049","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa0905079","article-title":"Ecallantide for the treatment of acute attacks in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2010.04.012","article-title":"EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema","volume":"104","author":"Levy","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2026.02.018_bib0051","unstructured":"Firazyr [prescribing information]. Cambridge, MA: Takeda Pharmaceuticals; 2025."},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0052","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B\u2082 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0053","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jaip.2017.04.010","article-title":"Treatment effect and safety of icatibant in pediatric patients with hereditary angioedema","volume":"5","author":"Farkas","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.02.018_bib0054","series-title":"Package insert","year":"2025"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa2314192","article-title":"Oral sebetralstat for on-demand treatment of hereditary angioedema attacks","volume":"391","author":"Riedl","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2026.02.018_bib0056","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.anai.2025.10.017","article-title":"Sebetralstat for ON-DEMAND treatment of hereditary angioedema in pediatric (2-11Y) patients: interim results from KONFIDENT-KID","volume":"135","author":"Adatia","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.anai.2026.02.018_bib0057","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/all.12186","article-title":"Risk of angioedema following invasive or surgical procedures in HAE type I and II\u2013the natural history","volume":"68","author":"Aygoren-Pursun","year":"2013","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.02.018_bib0058","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/aap.2021.42.210006","article-title":"Short-term prophylaxis for children and adolescents with hereditary angioedema","volume":"42","author":"Ajewole","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0059","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.anai.2016.10.006","article-title":"Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: findings from an international patient registry","volume":"118","author":"Magerl","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tripleo.2011.02.034","article-title":"Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study","volume":"112","author":"Bork","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.1016\/j.anai.2026.02.018_bib0061","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0062","first-page":"109","article-title":"Conestat alfa (ruconest): first recombinant C1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema","volume":"40","author":"Cruz","year":"2015","journal-title":"P T"},{"issue":"2","key":"10.1016\/j.anai.2026.02.018_bib0063","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaip.2019.08.011","article-title":"Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema","volume":"8","author":"Valerieva","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0064","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0091-6749(75)90077-9","article-title":"Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery","volume":"55","author":"Jaffe","year":"1975","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.02.018_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0066","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.anai.2018.07.025","article-title":"Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency","volume":"121","author":"Craig","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0067","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaip.2023.09.009","article-title":"Lanadelumab in patients 2 to less than 12 years old with hereditary angioedema: results from the Phase 3 SPRING study","volume":"12","author":"Maurer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.02.018_bib0068","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.anai.2025.07.012","article-title":"Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim results","volume":"135","author":"Bernatoniene","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10382","key":"10.1016\/j.anai.2026.02.018_bib0069","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(23)00350-1","article-title":"Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Craig","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2026.02.018_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2402478","article-title":"Efficacy and safety of donidalorsen for hereditary angioedema","volume":"391","author":"Riedl","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:43:33Z","timestamp":1793605413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1081120626000785"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.02.018","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of pediatric and adolescent hereditary angioedema","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}